Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL134994 | 1.00 | SLC34A1 (0.73) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL8670758 | 1.00 | SLC34A1 (0.73) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL29254617 | 1.00 | SLC34A1 (0.73) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1172442 | 0.95 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL8113536 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1259461 | 0.95 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL11166287 | 0.95 | SLC34A1 (0.82) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL9254108 | 0.95 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL20537386 | 0.95 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL16822371 | 0.95 | SLC34A1 (0.67) | SLC34A1LMNAKDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 519 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118000028-A | Water-saving cultivation method for rice | 新疆农业科学院核技术生物技术研究所（新疆维吾尔自治区生物技术研究中心） | 2024-05-10 | — | — | CN | claimed |
| CN-111320588-B | Method for purifying Lesinurad | 上海奥博生物医药股份有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-112274633-B | Cord Ma Lutai blood glucose-reducing weight-reducing microneedle patch and preparation method and application thereof | 广州新济薇娜生物科技有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-114107413-B | Method for producing cytidine by enzyme catalysis of cytosine and application thereof | 江苏香地化学有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116288426-A | Method for constructing multilayer biological membrane electrode and multilayer biological membrane electrode | 清华大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115671067-A | Application of huanglong dripping pills in treating and preventing irritable bowel syndrome | 深圳万和制药有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-115463647-A | Special stationary phase for protein separation and preparation and application thereof | 苏州瑞恒嘉航医疗科技有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-112461967-B | Carbon (C) 13 C]Method for detecting melamine and cyanuric acid in urea | 江苏华亘泰来生物科技有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-115413678-A | Wettable powder containing verticillium dahliae activator protein and application | 中捷四方生物科技股份有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-114989232-A | Reduction method of glucolactone | 汉瑞药业(荆门)有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-1786170-A | High efficiency transglyco beta galactoside gene | UNIV SHANDONG (CN) | 2006-06-14 | — | — | CN | claimed |
| CN-1778928-A | Transglycosyl alpha-galactoglucosidezyme gene | UNIV SHANDONG (CN) | 2006-05-31 | — | — | CN | claimed |
| CN-1732185-A | Method for crystallizing human serum albumin | TAURUS HSA LLC (US) | 2006-02-08 | — | — | CN | claimed |
| CN-1429116-A | Novel pharmaceutical composition | HOFFMANN LA ROCHE (CH) | 2003-07-09 | — | — | CN | claimed |
| WO-2001059148-A1 | A BACTERIAL VAGINOSIS SCREENING TECHNIQUE AND A DIAGNOSTIC KIT FOR USE THEREIN | LOUDERBACK ALLAN LEE (US) | 2001-08-16 | — | — | WO | claimed |
| EP-0472500-B1 | Stabilized chlorodeoxysugar sweetening agents in solid form and methods for preparing same | MCNEIL PPC INC (US) | 1998-11-25 | — | — | EP | claimed |
| EP-0472500-A1 | Stabilized chlorodeoxysugar sweetening agents in solid form and methods for preparing same | WARNER-LAMBERT COMPANY (US) | 1992-02-26 | — | — | EP | claimed |
| EP-0244315-B1 | PROCESS FOR PREPARING AN AQUOUS PHARMACEUTICAL SOLUTION OF AN ORGANIC ACID AS THE ACTIVE INGREDIENT | LABORATOIRES CHAUVIN S.A. (FR) | 1990-09-05 | — | — | EP | claimed |
| US-4866088-A | BUFFERED OPTHALMIC SOLUTION OF INDOMETHACIN | LABORATOIRES CHAUVIN-BLACHE (FR) | 1989-09-12 | — | — | US | claimed |
| US-4196201-A | Non-irritating eye make-up remover composition | L'OREAL (FR) | 1980-04-01 | — | — | US | claimed |